- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Lupin Limited — Updates, 24-10-2025: Press Release
24-10-2025 | 09:33 am
24-10-2025 | 09:33 am
Lupin launched an authorized generic version of Ravicti® (Glycerol Phenylbutyrate) Oral Liquid, 1.1g/mL, in the US. This expands their portfolio for chronic management of urea cycle disorders, potentially boosting market share and revenue.
No comments yet. Be the first to comment!